Cases with predominant HER2 admixture were enriched in groups 5 and 8, which are typically associated with the HER2 subtype, but no admixed Basal cases were assigned to IntClust 10, which is associated with triple-negative breast cancer. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.